SABUS STEVE M (SVP & Chief Commercial Officer) received a stock award from TURNING POINT THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/1/2022ACC: 0001209191-22-033207
Officer· SVP & Chief Commercial Officer
Since May 2022
+201.67K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
201.67K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+36.67K
Price / share
—
Trade value
—
% of position
New position
5/31/2022
0.00→36.67K
Total
Net shares
+36.67K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/31/2022 | A · Award | +36.67K | — | — | New position | 0.00 | 36.67K |
| Total | +36.67K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
165K shares
Shares
+165K
Strike price
35.37
Held after
165K
Exercisable
—
5/31/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock165K shares | 5/31/2022 | A · Award | +165K | 35.37 | — | 165K |